ESR1 and breast carcinoma: Structural conformational changes of ERα and ERβ that can be induced via their interaction with other regulatory molecules in breast cancer cells, may affect estrogens receptors’ binding or interaction with ERs potential agonists or antagonists, including metalloestrogens as has been previously observed [22, 23].